Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+8.7%
5Y CAGR+13.5%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+8.7%/yr
vs +10.9%/yr prior
5Y CAGR
+13.5%/yr
Recent deceleration
Acceleration
-2.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.07B | +6.0% |
| 2024 | $8.55B | -4.6% |
| 2023 | $8.97B | +27.2% |
| 2022 | $7.05B | +28.9% |
| 2021 | $5.47B | +13.5% |
| 2020 | $4.82B | -5.7% |
| 2019 | $5.11B | +9.5% |
| 2018 | $4.67B | +16.1% |
| 2017 | $4.02B | +22.2% |
| 2016 | $3.29B | - |